Meyer, A., Rudant, J., Drouin, J., Coste, J., Carbonnel, F., & Weill, A. (2019). The effectiveness and safety of infliximab compared with biosimilar CT‐P13, in 3112 patients with ulcerative colitis. Aliment Pharmacol Ther.

Meyer, Antoine, Jérémie Rudant, Jérôme Drouin, Joël Coste, Franck Carbonnel, and Alain Weill. "The Effectiveness and Safety of Infliximab Compared With Biosimilar CT‐P13, in 3112 Patients With Ulcerative Colitis." Aliment Pharmacol Ther 2019.

Meyer, Antoine, et al. "The Effectiveness and Safety of Infliximab Compared With Biosimilar CT‐P13, in 3112 Patients With Ulcerative Colitis." Aliment Pharmacol Ther 2019.